secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2022-05-17T23:59:59+00:00
Accession:  0000950170-22-010201
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Mednax appoints James D. Swift as COO; shareholders reject say-on-pay
---------------------------------------------------------------------

- James D. Swift, MD promoted from EVP/Chief Development Officer to EVP/COO, effective May 12, 2022.
- Say-on-pay vote failed: 45.2 million against vs 34.6 million for (56.6% against).
- All director nominees elected; Weiss and Starcher each received over 9 million against votes.
- Ratification of PwC as auditor for FY2022 passed with 78.3 million votes for.
- Shareholders approved Second Amended and Restated Articles of Incorporation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017022010201/0000950170-22-010201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017022010201/md-20220512.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-010201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer